![Kjell Andersson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 2 M $ au 30/06/2026
Kjell Andersson is the founder of Cinclus Pharma Holding AB, which was founded in 2014.
He held the title of Chief Scientific Officer at the company.
Currently, Dr. Andersson is working as a Director at OBX Invest AB. In terms of education, he obtained a doctorate degree from the University of Lund and an undergraduate degree from the University of Gothenburg.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 1 908 000 ( 4,1% ) | 2 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CINCLUS PHARMA HOLDING AB | Fondateur | 01/01/2014 |
OBX Invest AB | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Gothenburg
 University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Operates as a holding company through its subsidiaries develops small molecules for treatment of gastric acid related diseases | Health Technology |
OBX Invest AB |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
